2026 annual financial data
Grace Therapeutics 2026 Operating margin
Grace Therapeutics 2026 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -11,077,000 USD and net income was -7,793,000 USD.
Operating cash flow was -8,869,000 USD.
Get free Grace Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -11,077,000 USD
- Net income
- -7,793,000 USD
- Operating cash flow
- -8,869,000 USD